These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31602204)

  • 41. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations.
    Zeng Z; Chen HJ; Yan HH; Yang JJ; Zhang XC; Wu YL
    Int J Biol Markers; 2013 Sep; 28(3):249-58. PubMed ID: 23873621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing.
    Sun JM; Choi YL; Ji JH; Ahn JS; Kim KM; Han J; Ahn MJ; Park K
    Ann Oncol; 2015 Jan; 26(1):161-166. PubMed ID: 25355724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
    Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
    BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
    Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
    J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.
    Lee YJ; Shim HS; Kang YA; Hong SJ; Kim HK; Kim H; Kim SK; Choi SH; Kim JH; Cho BC
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1937-44. PubMed ID: 20237940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statistical modeling of lung cancer: answering relative questions.
    Cong C; Kepner J; Tsokos CP
    Int J Biomed Sci; 2011 Mar; 7(1):70-6. PubMed ID: 23675223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EGFR and erbB2 mutation status in Japanese lung cancer patients.
    Sasaki H; Shimizu S; Endo K; Takada M; Kawahara M; Tanaka H; Matsumura A; Iuchi K; Haneda H; Suzuki E; Kobayashi Y; Yano M; Fujii Y
    Int J Cancer; 2006 Jan; 118(1):180-4. PubMed ID: 16003726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
    Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
    Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
    [No Abstract]   [Full Text] [Related]  

  • 49. Multiple primary malignancies in patients with non-small cell lung cancer.
    Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
    Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
    Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
    Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.
    Yamaguchi N; Vanderlaan PA; Folch E; Boucher DH; Canepa HM; Kent MS; Gangadharan SP; Majid A; Kocher ON; Goldstein MA; Huberman MS; Costa DB
    Lung Cancer; 2013 Oct; 82(1):31-7. PubMed ID: 23932486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between familial cancer history and epidermal growth factor receptor mutations in Taiwanese never smokers with non-small cell lung cancer: a case-control study.
    Cheng PC; Cheng YC
    J Thorac Dis; 2015 Mar; 7(3):281-7. PubMed ID: 25922704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].
    Zhou CC; Zhou SW; Pan H; Su B; Gao ZQ
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):119-23. PubMed ID: 17645848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer.
    Castro AS; Parente B; Gonçalves I; Antunes A; Barroso A; Conde S; Neves S; Machado JC
    Rev Port Pneumol; 2013; 19(1):7-12. PubMed ID: 23265235
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Gaur P; Bhattacharya S; Kant S; Kushwaha RAS; Singh G; Pandey S
    World J Oncol; 2018 Nov; 9(5-6):151-155. PubMed ID: 30524640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world Data.
    Nakahama K; Izumi M; Yoshimoto N; Fukui M; Sugimoto A; Nagamine H; Ogawa K; Sawa K; Tani Y; Kaneda H; Mitsuoka S; Watanabe T; Asai K; Kawaguchi T
    Anticancer Res; 2023 May; 43(5):2185-2197. PubMed ID: 37097681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial.
    Boye M; Wang X; Srimuninnimit V; Kang JH; Tsai CM; Orlando M; Puri T; Kim JS; Rajan N; Yang JC
    Clin Lung Cancer; 2016 Mar; 17(2):150-60. PubMed ID: 26809984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
    Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.